Halaven and General physical health deterioration - a phase IV clinical study of FDA data

Summary:

General physical health deterioration is reported as a side effect among people who take Halaven (eribulin mesylate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Amlodipine, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have General physical health deterioration when taking Halaven. It is created by eHealthMe based on reports of 3,873 people who have side effects when taking Halaven from the FDA, and is updated regularly.

What is Halaven?

Halaven has active ingredients of eribulin mesylate. eHealthMe is studying from 3,881 Halaven users. Check the latest studies of Halaven.

What is General physical health deterioration?

General physical health deterioration (weak health status) is found to be associated with 2,267 drugs and 2,923 conditions by eHealthMe. Check the latest studies of General physical health deterioration.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

3,873 people reported to have side effects when taking Halaven.
Among them, 65 people (1.68%) have General physical health deterioration.

Could Halaven cause General physical health deterioration?

Among these 65 people:

How long have people been on Halaven when they have General physical health deterioration? *

What is the gender of people who have General physical health deterioration when taking Halaven? *

female: 100 %
male: 0.0 %

What is the age of people who have General physical health deterioration when taking Halaven? *

What are other drugs people take besides Halaven? *

What are other side effects people have besides General physical health deterioration? *

Leukopenia (less number of white blood cells in blood): 20 people, 30.77%
Fatigue (feeling of tiredness): 17 people, 26.15%
Nausea (feeling of having an urge to vomit): 17 people, 26.15%
Malignant Neoplasm Progression (cancer tumour came back): 13 people, 20.00%
Weakness: 12 people, 18.46%
Nausea And Vomiting: 11 people, 16.92%
Dyspnea (difficult or laboured breathing): 11 people, 16.92%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 10 people, 15.38%
Dizziness: 10 people, 15.38%
Anaemia (lack of blood): 10 people, 15.38%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 30 people, 46.15%
Breast Cancer: 26 people, 40.00%
Breast Cancer Female: 2 people, 3.08%
Pain: 2 people, 3.08%
Metastases To Bone (cancer spreads to bone): 2 people, 3.08%
Urinary Sediment Present: 1 person, 1.54%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 1.54%
Cardiac Failure: 1 person, 1.54%
Constipation: 1 person, 1.54%
Dizziness: 1 person, 1.54%

* Approximation only. Some reports may have incomplete information.

Do you take Halaven and have General physical health deterioration?

- Check whether General physical health deterioration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Halaven:

Halaven (3,881 reports)

Browse all side effects of Halaven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with General physical health deterioration:

General physical health deterioration (2,267 drugs)

Browse all the conditions that are associated with General physical health deterioration:

General physical health deterioration (2,923 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eribulin mesylate (the active ingredients of Halaven) and Halaven (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.